Thromboembolism in Anorexia Nervosa
TEAN
1 other identifier
observational
80
2 countries
5
Brief Summary
BACKGROUND: Sudden death due to thromboembolic (TE) events in patients with anorexia nervosa (AN) is well known. However, the incidence of TE events and the hemostatic balance in patients with AN are sparsely investigated. Also, associations between re-nutrition and the hemostatic balance have not been studied. OBJECTIVE: To describe the incidence of TE events in patients with AN compared to the background population, to characterize the hemostatic balance in AN compared to normal-weight women, and to assess the associations between the hemostatic balance and nutritional status, insulin sensitivity and cortisol level in women with AN. METHODS: The incidence of TE will be described using a Danish cohort of AN patients (n=10,049) with follow-up in national registries. A comprehensive battery of hemostatic biomarkers will be compared in a case-control study of 40 patients with AN and associations between hemostasis and nutritional status will be studied.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2022
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 5, 2022
CompletedFirst Posted
Study publicly available on registry
October 12, 2022
CompletedStudy Start
First participant enrolled
November 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 10, 2024
CompletedOctober 15, 2024
October 1, 2024
1.9 years
October 5, 2022
October 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of thromboembolic events
Arterial and venous thrombosis. Non-fatal outcomes of a thromboembolic event will be validated by the use of anticoagulants in the period immediately after the outcome defining event.
Data on thromboembolic events are collected from health registries. Data is collected through study completion of the time frame in the registry, up to 26 years.
Other Outcomes (2)
Hemostatic balance
The study is cross-sectional. Time frame for completion of participation in the study is 1 day.
Rotational Thromboelastometry (ROTEM)-variables
The study is cross-sectional. Time frame for completion of participation in the study is 1 day.
Study Arms (2)
Patients
Will have thromboembolic incidence rate evaluated and will have a battery of hemostatic markers analyzed
Controls
Will have thromboembolic incidence rate evaluated and will have a battery of hemostatic markers analyzed
Interventions
Eating Disorder Inventory - third version (EDI-3) Eating Disorder Quality of Life Scale (EDQLS)
Eligibility Criteria
Patients with anorexia nervosa and healthy, age-matched controls.
You may qualify if:
- Fulfilling Diagnostic and Statistical Manual V (DSM-5) criteria for AN
- Age 18 - 50 years
- Female sex
You may not qualify if:
- Somatic comorbidity requiring systemic medications
- Previous thromboembolic event and/or known genetic predisposition
- Use of p.o. hormonal contraception
- Smoking
- BMI 18.5 - 25.0
- Age 18 - 50 years
- Female sex
- Somatic comorbidity requiring systemic medications
- Previous thromboembolic event and/or known genetic predisposition
- Use of p.o. hormonal contraception
- Smoking
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
Clinical Pharmacology and Pharmacy, University of Southern Denmark
Odense, Fyn, 5000, Denmark
Department of Child and Adolescent Mental Health Odense, Mental Health Services in the Region of Southern Denmark
Odense, Fyn, 5000, Denmark
The Nutritional Unit, Department of Endocrinology, Center for Eating Disorders, Odense University Hospital and Psychiatry in the region of Southern Denmark
Odense, Fyn, 5220, Denmark
Unit for Thrombosis Research, Department of Clinical Biochemistry, Hospital of South West Jutland
Esbjerg, Jylland, 6700, Denmark
Department of Clinical Sciences, Umeå University
Umeå, Västerbotten County, Sweden
Biospecimen
Blood samples
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor
Study Record Dates
First Submitted
October 5, 2022
First Posted
October 12, 2022
Study Start
November 15, 2022
Primary Completion
October 10, 2024
Study Completion
October 10, 2024
Last Updated
October 15, 2024
Record last verified: 2024-10